Search

Displaying results 2191 - 2200 of 9680 in total
  1. Drug

    Furacrinic acid

    go.drugbank.com/drugs/DB21223
    Experimental

    Furacrinic acid is a small molecule drug. Furacrinic acid has a monoisotopic molecular weight of 258.09 Da.

  2. Drug

    Xantofyl palmitate

    go.drugbank.com/drugs/DB21273
    Experimental

    Xantofyl palmitate is a small molecule drug. Xantofyl palmitate has a monoisotopic molecular weight of 1044.89 Da.

  3. Drug

    Cromoglicate lisetil

    go.drugbank.com/drugs/DB21297
    Experimental

    Cromoglicate lisetil is a small molecule drug. Cromoglicate lisetil has a monoisotopic molecular weight of 652.23 Da.

  4. Drug

    Iobutoic acid

    go.drugbank.com/drugs/DB21443
    Experimental

    Iobutoic acid is a small molecule drug. Iobutoic acid has a monoisotopic molecular weight of 670.82 Da.

  5. Drug

    Iodocetylic acid I-123

    go.drugbank.com/drugs/DB19593
    Experimental

    Iodocetylic acid I-123 is a small molecule drug. Iodocetylic acid I-123 has a monoisotopic molecular weight of 378.14 Da.

  6. Drug

    Atorvastatin

    go.drugbank.com/drugs/DB01076
    ApprovedInvestigational

    Atorvastatin (Lipitor®), is a lipid-lowering drug included in the statin class of medications. … [T568] It is a pentasubstituted pyrrole [A177415] formed by two contrasting moieties with an achiral heterocyclic core unit and a 3,5-dihydroxypentanoyl side chain identical to its parent compound.

    Mixtures: TIAZOMET ® A 40/10 TABLETASProducts: COLASTIN-L 10 MG FILM KAPLI TABLET, 30 ADET, COLASTIN-L 10 MG FILM KAPLI TABLET, 90 ADET
  7. Drug

    AL-034

    go.drugbank.com/drugs/DB17471
    Investigational

    AL-034 (TQ-A3334) is an oral toll-like receptor 7 agonist developed for the treatment of chronic hepatitis B (CHB) viral infection.

  8. Drug

    Tirabrutinib

    go.drugbank.com/drugs/DB15227
    Investigational

    Tirabrutinib is under investigation in clinical trial NCT02626026 (Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects With Rheumatoid Arthritis (RA)).

  9. Drug

    Recanaclotide

    go.drugbank.com/drugs/DB15417
    Investigational

    Recanaclotide is under investigation in clinical trial NCT01712412 (Phase 2a Study of IW-9179 to Treat Functional Dyspepsia).

  10. Drug

    Copper oxodotreotide Cu-64

    go.drugbank.com/drugs/DB15873
    Approved

    [A220348] Further studies should be performed to compare the two tracers. … [A220348] Copper Cu 64 dotatate has a longer half-life and can be produced once a day as opposed to several times a day, and lower positron energy lending to improved spatial resolution.